Share on StockTwits

Tauriga Sciences (NASDAQ:TAUG) CEO Stella M. Sung acquired 200,000 shares of Tauriga Sciences stock on the open market in a transaction that occurred on Tuesday, June 24th. The shares were purchased at an average cost of $0.02 per share, for a total transaction of $4,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 21,300,000 shares of the company’s stock, valued at approximately $426,000. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Tauriga Sciences (NASDAQ:TAUG) traded up 16.67% on Thursday, hitting $0.028. 1,882,352 shares of the company’s stock traded hands. Tauriga Sciences has a one year low of $0.01 and a one year high of $0.11. The stock’s 50-day moving average is $0.02 and its 200-day moving average is $0.03. The company’s market cap is $14.6 million.

Tauriga Sciences, Inc, formerly Immunovative, Inc, develops the next generation immunotherapies to treat cancer.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.